Insider Trading History of Adamis Anthony P

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Adamis Anthony P since 2005. This trader's CIK number is 1277479. At the time of last reporting, Adamis Anthony P was the Officer of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT). Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..

Note that in the past ADAMIS ANTHONY P also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eyetech Pharmaceuticals Inc (EYET) by Adamis Anthony P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 EYET 0 $0 15,975 $196,437 0 $0

Yearly summary of insider trading at Eyepoint Pharmaceuticals, Inc. (EYPT) by Adamis Anthony P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 EYPT 0 $0 0 $0 2,000 $0
2023 EYPT 0 $0 0 $0 2,000 $0


Insider trading activities at 2 companies by Adamis Anthony P:

1. Eyetech Pharmaceuticals Inc (EYET)

2. Eyepoint Pharmaceuticals, Inc. (EYPT)

Table 1. Insider trading of Eyetech Pharmaceuticals Inc (EYET) by Adamis Anthony P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-08-01 EYET Sale 5,325 11.35 60,438
2005-07-01 EYET Sale 5,325 12.59 67,041
2005-06-01 EYET Sale 5,325 12.95 68,958

Table 2. Insider trading of Eyepoint Pharmaceuticals, Inc. (EYPT) by Adamis Anthony P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-06-23 EYPT Option Ex 2,000 .00 0
2023-06-23 EYPT Option Ex 2,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adamis Anthony P (Officer of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.